High incidence of hepatotoxicity of isoniazid treatment for tuberculosis chemoprophylaxis in patients with rheumatoid arthritis treated with methotrexate or sulfasalazine and anti-tumour necrosis factor inhibitors
Open Access
- 1 December 2003
- journal article
- letter
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 62 (12) , 1241-1242
- https://doi.org/10.1136/ard.2002.004598
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of AmericaAmerican Journal of Respiratory and Critical Care Medicine, 2003
- TNF inhibition as therapy for rheumatoid arthritisExpert Opinion on Investigational Drugs, 2002
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trialThe Lancet, 1999
- Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion ProteinNew England Journal of Medicine, 1997